Mesai Biotech develops macromolecular drugs to treat tumors.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Hangzhou
State: Zhejiang
Zip:
Country: China
Mesai Biotech produces a range of tumor immunotherapy drugs to provide new therapies. In addition, they offer technical services that include recombinant protein customization, monoclonal antibody drug screening, structural biology, antibody engineering, antibody epitope determination, and more.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2022 | Series A | 2 | - |
Cowin Venture Ming Bioventures Cowin Venture Ming Bioventures |
9/2022 | Series A | 2 | - |
Cowin Venture Ming Bioventures Cowin Venture Ming Bioventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|